Comparison of Pharmacokinetic and Pharmacodynamic Profiles of G-Pump (Glucagon Infusion) vs. GlucaGen Delivered Subcutaneously to Subjects With Type 1 Diabetes (T1DM)

Trial Profile

Comparison of Pharmacokinetic and Pharmacodynamic Profiles of G-Pump (Glucagon Infusion) vs. GlucaGen Delivered Subcutaneously to Subjects With Type 1 Diabetes (T1DM)

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Aug 2016

At a glance

  • Drugs Glucagon (Primary)
  • Indications Hypoglycaemia
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors XERIS Pharmaceuticals
  • Most Recent Events

    • 26 Oct 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
    • 12 Aug 2014 Planned End Date changed from 1 Jul 2014 to 1 Nov 2014 as reported by ClinicalTrials.gov record.
    • 12 Aug 2014 Planned primary completion date changed from 1 Jun 2014 to 1 Aug 2014 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top